The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody–drug conjugate for the treatment of newly diagnosed acute myeloid leukemia

Egan PC, Reagan JL

OncoTargets and Therapy 2018, 11:8265-8272

Published Date: 22 November 2018